|
|
||||||||
Departments of Clinical Physiology, Diagnostic and Interventional Radiology and Cardiology, University Hospital of Northern Sweden, Umeå, Sweden
Correspondence: For correspondence or reprints contact: Peter Rask, MD, Dept. of Clinical Physiology, University Hospital of Northern Sweden, 901 85 Umeå, Sweden.
ABSTRACT
Dipyridamole SPECT detects significant coronary artery disease (CAD) in patients without aortic stenosis. This study was done to establish normal 201TI distribution limits in patients with aortic stenosis and to apply these normal limits to patients with aortic stenosis and angiographically significant CAD (
75% area reduction). Methods: Fifty-two patients (mean age 68 yr; mean valve area 0.67 cm2) were examined with 201TI SPECT after dipyridamole infusion (0.56 mg/kg during 4 min). After tomographic reconstruction, basal, mid-ventricular and apical short-axis slices were selected. The highest activity in each six-degree segment was normalized to the maximal activity of each slice. Results: Significant CAD was found in 24 patients. Five patients without CAD, but with localized hypokinesia or left bundle-branch block, were excluded from the reference group which finally consisted of 16 patients. Sensitivity for CAD was 88% when the lowest relative activity in each segment was used as the lower limit of normal. With 2 s.d. and 2.5 s.d. curves the sensitivity was 83% and 75%, respectively. Gender-specific limits were not used. Nonsignificant CAD was found in seven patients (<75% stenoses). Conclusions: This study presents the normal distribution of 201TI uptake for patients with aortic stenosis, using dipyridamole SPECT. The range method had the highest sensitivity for detection of significant CAD.
Key Words: aortic stenosis coronary artery disease dipyridamole thallium-201 SPECT computer evaluation
This article has been cited by other articles:
![]() |
W. B. Meijboom, N. R. Mollet, C. A.G. Van Mieghem, J. Kluin, A. C. Weustink, F. Pugliese, E. Vourvouri, F. Cademartiri, A. J.J.C. Bogers, G. P. Krestin, et al. Pre-Operative Computed Tomography Coronary Angiography to Detect Significant Coronary Artery Disease in Patients Referred for Cardiac Valve Surgery J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1658 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Scanlon, D. P. Faxon, A.-M. Audet, B. Carabello, G. J. Dehmer, K. A. Eagle, R. D. Legako, D. F. Leon, J. A. Murray, S. E. Nissen, et al. ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1756 - 1824. [Full Text] [PDF] |
||||
![]() |
S. Maffei, M. Baroni, M. Terrazzi, F. Paoli, P. Ferrazzi, and A. Biagini Preoperative Assessment of Coronary Artery Disease in Aortic Stenosis: A Dipyridamole Echocardiographic Study Ann. Thorac. Surg., February 1, 1998; 65(2): 397 - 402. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |